We served as co-counsel to Sanofi-Aventis S.A. in shareholder class actions filed following announcement of its acquisition of Chattem, Inc. for $1.9 billion.
Sanofi S.A. (EURONEXT: SAN; NYSE: SNY). is a global and diversified healthcare leader, that discovers, develops and distributes therapeutic solutions focused on patients’ needs. The company name was Sanofi-Aventis S.A. from 2004 – 2011.
We served as co-counsel to Sanofi-Aventis S.A. in shareholder class actions filed following announcement of its acquisition of Chattem, Inc. for $1.9 billion.
Sanofi S.A. (EURONEXT: SAN; NYSE: SNY). is a global and diversified healthcare leader, that discovers, develops and distributes therapeutic solutions focused on patients’ needs. The company name was Sanofi-Aventis S.A. from 2004 – 2011.